Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism GPR75 inhibitors(G protein-coupled receptor 75 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Phase 2 | Canada | 30 Nov 2021 | |
Neoplasms | Phase 2 | Canada | 30 Nov 2021 | |
Obesity | Preclinical | Canada | 01 Feb 2025 |